Article

Optimising primary molecular profiling in NSCLC

2023-08-21

Abstract excerpt

<h4>Introduction</h4> Molecular profiling of NSCLC is essential for optimising treatment decisions, but often incomplete. We assessed the efficacy of protocolised molecular profiling in the current standard-of-care (SoC) in a prospective observational study in the Netherlands and measured the effect of providing standardised diagnostic procedures. We also explored the potential of plasma-based molecular profiling...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 991b4576-65b9-585f-8382-cc6ad1e989f3
DOI: 10.1101/2023.08.20.23294346

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Optimising primary molecular profiling in NSCLCDOI 10.1101/2023.08.20.23294346Read

Optimising primary molecular profiling in non-small cell lung cancer.Semantic proximity Read

Implementing Genomic Testing for Lung Cancer Into Routine Clinical Practice - The Welsh Experience.Semantic proximity Read

Overview of Molecular Diagnostics in Irish Clinical OncologySemantic proximity Read

Overview of Molecular Diagnostics in Irish Clinical OncologySemantic proximity Read

Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315).Semantic proximity Read

Detecting actionable mutations from matched plasma-based versus tissue next-generation sequencing in advanced non-small cell lung cancer: a retrospective single centre analysis on siteSemantic proximity Read

The implementation of liquid biopsies in routine care of patients with advanced solid cancer (LIQPLAT): a study protocol for a single arm trialSemantic proximity Read

Comprehensive liquid biopsy analysis for monitoring NSCLC patients under second-line osimertinib treatmentSemantic proximity Read

Barries in precision medicine implementation among Advanced Nonsquamous Cell Lung Cancer-patients: A Real-World-Evidence ScenarioSemantic proximity Read

Lung Master Protocol (Lung-MAP)—A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400Semantic proximity Read

Integration of rapid PCR testing as an adjunct to NGS in diagnostic pathology services within the UK: evidence from a case series of non-squamous, non-small cell lung cancer (NSCLC) patients with follow-up.Semantic proximity Read

Challenges in molecular testing in non-small-cell lung cancer patients with advanced disease.Semantic proximity Read